New: Introducing the Finviz Crypto Map

Learn More
Index- P/E- EPS (ttm)-4.75 Insider Own0.64% Shs Outstand199.30M Perf Week-9.37%
Market Cap2.59B Forward P/E6.84 EPS next Y1.90 Insider Trans1.20% Shs Float198.21M Perf Month-22.02%
Enterprise Value4.72B PEG- EPS next Q0.42 Inst Own99.19% Short Float3.96% Perf Quarter-18.54%
Income-949.00M P/S0.70 EPS this Y5.34% Inst Trans0.94% Short Ratio2.69 Perf Half Y-32.54%
Sales3.67B P/B1.32 EPS next Y7.78% ROA-14.64% Short Interest7.84M Perf YTD-31.72%
Book/sh9.83 P/C7.20 EPS next 5Y7.12% ROE-37.78% 52W High27.48 -52.84% Perf Year-46.34%
Cash/sh1.80 P/FCF18.73 EPS past 3/5Y- - ROIC-22.22% 52W Low12.16 6.58% Perf 3Y-63.90%
Dividend Est.0.66 (5.13%) EV/EBITDA7.46 Sales past 3/5Y-3.58% -1.20% Gross Margin51.92% Volatility5.22% 3.78% Perf 5Y-70.99%
Dividend TTM0.64 (4.94%) EV/Sales1.29 EPS Y/Y TTM-445.83% Oper. Margin7.87% ATR (14)0.61 Perf 10Y-77.23%
Dividend Ex-DateSep 26, 2025 Quick Ratio1.11 Sales Y/Y TTM-5.78% Profit Margin-25.85% RSI (14)22.65 Recom2.61
Dividend Gr. 3/5Y14.17% 10.99% Current Ratio1.69 EPS Q/Q-1057.95% SMA20-15.03% Beta0.97 Target Price16.65
Payout- Debt/Eq1.27 Sales Q/Q-4.88% SMA50-17.54% Rel Volume2.51 Prev Close13.23
Employees14000 LT Debt/Eq1.18 EarningsAug 07 BMO SMA200-24.53% Avg Volume2.91M Price12.96
IPOAug 12, 1987 Option/ShortYes / Yes EPS/Sales Surpr.2.67% 0.10% Trades Volume7,536,020 Change-2.04%
Date Action Analyst Rating Change Price Target Change
Apr-15-25Downgrade Morgan Stanley Overweight → Equal-Weight $14
Mar-13-25Downgrade Needham Buy → Hold
Feb-14-25Initiated Wells Fargo Equal Weight $20
Jan-23-25Downgrade Jefferies Buy → Hold $30 → $20
Jan-07-25Downgrade Evercore ISI Outperform → In-line $20
Dec-04-24Initiated Mizuho Neutral $21
Nov-07-24Downgrade Leerink Partners Outperform → Market Perform
Oct-25-24Reiterated Needham Buy $34 → $29
Aug-20-24Reiterated Needham Buy $34
Feb-26-24Initiated Leerink Partners Outperform $42
Aug-08-25 09:45AM
07:25AM
Aug-07-25 02:15PM
01:49PM
11:06AM
09:40AM Loading…
09:40AM
09:30AM
07:15AM
06:49AM
06:00AM
Aug-06-25 12:50PM
Aug-05-25 11:10PM
Aug-04-25 11:40AM
09:40AM
08:35AM
10:00AM Loading…
Jul-31-25 10:00AM
Jul-30-25 05:30PM
Jul-28-25 09:50AM
12:01AM
Jul-22-25 11:16AM
09:40AM
06:00AM
Jul-21-25 04:07PM
03:04PM
12:21PM
08:30AM
Jul-18-25 11:40AM
09:40AM
09:28AM
Jul-16-25 12:26PM
09:26AM Loading…
Jul-14-25 09:26AM
08:33AM
Jul-10-25 08:30AM
Jul-09-25 09:50AM
Jul-03-25 09:40AM
Jul-02-25 11:40AM
09:40AM
Jun-27-25 05:38AM
Jun-25-25 11:31PM
Jun-17-25 09:40AM
Jun-16-25 11:40AM
09:40AM
Jun-12-25 08:34AM
Jun-11-25 10:28AM
Jun-05-25 05:35PM
07:47AM
Jun-04-25 09:50AM
May-30-25 12:20PM
11:40AM
09:40AM
09:40AM
09:35AM
May-29-25 04:30PM
May-27-25 04:15PM
May-20-25 07:48AM
May-19-25 07:00AM
May-14-25 11:40AM
09:40AM
09:40AM
May-13-25 09:50AM
09:16AM
May-09-25 03:14AM
12:56AM
12:43AM
May-08-25 12:42PM
11:53AM
09:30AM
07:10AM
06:10AM
06:00AM
May-07-25 12:10PM
09:15AM
May-05-25 11:12AM
May-02-25 12:35AM
May-01-25 05:55PM
10:01AM
12:34AM
Apr-30-25 05:25PM
Apr-28-25 05:01AM
Apr-25-25 07:54AM
Apr-17-25 05:55PM
Apr-16-25 09:21AM
Apr-15-25 05:12AM
Apr-14-25 10:10AM
Apr-09-25 07:00AM
Apr-06-25 12:54AM
Apr-03-25 03:58PM
Mar-31-25 11:13AM
Mar-22-25 12:31AM
Mar-20-25 02:45AM
Mar-17-25 08:45AM
Mar-13-25 01:34PM
09:24AM
Mar-12-25 11:30AM
Mar-11-25 09:10PM
09:02AM
Mar-10-25 05:03AM
Mar-04-25 04:30PM
04:01AM
Mar-03-25 09:15AM
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LUCIER GREGORY TDirectorMar 03 '25Buy16.5115,142249,99481,971Mar 03 06:33 PM
Coleman GlennFormer OfficerJan 27 '25Proposed Sale19.7515,759311,240Jan 27 10:35 AM
LUCIER GREGORY TDirectorNov 18 '24Buy18.375,00091,85071,730Nov 18 04:16 PM
LUCIER GREGORY TDirectorNov 15 '24Buy18.281,00018,27916,000Nov 18 04:16 PM
Campion Simon DPresident, CEO & Member of BODNov 12 '24Buy17.7211,306200,341272,247Nov 13 04:41 PM
NVST Envista Holdings Corp daily Stock Chart
Index- P/E64.58 EPS (ttm)0.31 Insider Own2.18% Shs Outstand166.80M Perf Week-2.83%
Market Cap3.36B Forward P/E16.53 EPS next Y1.22 Insider Trans0.00% Shs Float162.57M Perf Month-2.32%
Enterprise Value3.85B PEG2.68 EPS next Q0.28 Inst Own116.75% Short Float6.76% Perf Quarter13.90%
Income53.80M P/S1.32 EPS this Y51.92% Inst Trans-2.22% Short Ratio4.67 Perf Half Y-7.11%
Sales2.55B P/B1.08 EPS next Y10.42% ROA0.97% Short Interest10.99M Perf YTD4.92%
Book/sh18.82 P/C3.03 EPS next 5Y24.06% ROE1.76% 52W High23.00 -12.00% Perf Year28.43%
Cash/sh6.68 P/FCF13.04 EPS past 3/5Y- - ROIC1.14% 52W Low14.22 42.33% Perf 3Y-48.86%
Dividend Est.- EV/EBITDA12.98 Sales past 3/5Y0.02% -1.82% Gross Margin54.79% Volatility3.79% 3.15% Perf 5Y-8.54%
Dividend TTM- EV/Sales1.51 EPS Y/Y TTM104.10% Oper. Margin7.13% ATR (14)0.73 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.08 Sales Y/Y TTM0.76% Profit Margin2.11% RSI (14)52.69 Recom2.64
Dividend Gr. 3/5Y- - Current Ratio2.44 EPS Q/Q102.32% SMA200.73% Beta0.99 Target Price21.42
Payout- Debt/Eq0.51 Sales Q/Q7.74% SMA503.38% Rel Volume0.63 Prev Close20.09
Employees12300 LT Debt/Eq0.50 EarningsJul 31 AMC SMA2006.05% Avg Volume2.35M Price20.24
IPOSep 18, 2019 Option/ShortYes / Yes EPS/Sales Surpr.12.21% 6.58% Trades Volume1,698,275 Change0.75%
Date Action Analyst Rating Change Price Target Change
May-27-25Upgrade Robert W. Baird Neutral → Outperform $23
Dec-04-24Initiated Mizuho Underperform $20
Oct-31-24Upgrade Leerink Partners Underperform → Market Perform $16 → $23
Oct-08-24Initiated Wells Fargo Equal Weight $20
Aug-08-24Downgrade JP Morgan Overweight → Neutral $23 → $16
Apr-26-24Downgrade Morgan Stanley Overweight → Equal-Weight $33 → $21
Feb-26-24Initiated Leerink Partners Underperform $19
Feb-09-24Downgrade Jefferies Buy → Hold $30 → $23
Feb-08-24Downgrade William Blair Outperform → Mkt Perform
Jan-05-24Initiated UBS Neutral $26
Aug-07-25 11:40AM
09:40AM
Aug-05-25 06:16AM
Aug-04-25 09:15AM
Aug-01-25 12:20PM
06:30PM Loading…
Jul-31-25 06:30PM
05:45PM
05:35PM
04:41PM
04:05PM
Jul-29-25 11:09PM
10:00AM
Jul-25-25 12:00PM
09:55AM
Jul-24-25 10:00AM
03:35PM Loading…
Jul-23-25 03:35PM
Jul-22-25 11:40AM
Jul-21-25 04:07PM
Jul-17-25 11:58AM
Jul-16-25 11:02AM
Jul-14-25 07:54AM
Jul-09-25 04:10PM
09:00AM
Jul-06-25 11:34PM
Jun-26-25 11:40AM
04:21AM
Jun-19-25 08:17AM
Jun-18-25 07:52AM
Jun-10-25 12:00PM
11:40AM
12:00AM Loading…
Jun-09-25 12:00AM
May-28-25 02:42PM
May-22-25 04:15PM
May-21-25 04:53PM
May-16-25 11:31AM
06:43AM
May-15-25 11:23AM
May-13-25 09:16AM
May-09-25 05:00AM
May-06-25 07:10AM
May-02-25 08:45AM
03:19AM
May-01-25 09:05PM
06:30PM
05:45PM
04:48PM
04:05PM
Apr-30-25 07:16AM
Apr-29-25 01:19PM
Apr-28-25 06:13PM
06:10AM
05:01AM
Apr-24-25 10:01AM
05:02AM
Apr-19-25 06:02AM
Apr-16-25 05:05AM
Apr-10-25 07:16AM
Apr-08-25 04:15PM
Mar-31-25 11:13AM
09:51AM
Mar-24-25 09:00AM
Mar-23-25 08:06PM
Mar-10-25 05:03AM
Mar-07-25 11:30AM
Mar-04-25 04:01AM
Feb-25-25 04:10PM
Feb-19-25 09:00AM
Feb-10-25 08:01AM
Feb-06-25 11:49AM
02:17AM
Feb-05-25 06:30PM
05:35PM
05:21PM
04:31PM
04:05PM
Feb-04-25 04:10PM
07:08AM
Feb-03-25 09:30AM
Jan-29-25 10:00AM
Jan-27-25 04:10PM
Jan-14-25 04:10PM
Jan-08-25 04:05PM
Jan-07-25 04:10PM
Jan-02-25 09:40AM
Dec-10-24 07:00AM
Nov-28-24 09:30AM
Nov-20-24 04:10PM
Nov-19-24 04:10PM
Nov-06-24 07:39AM
Nov-04-24 09:15AM
Oct-31-24 10:50AM
03:19AM
Oct-30-24 07:30PM
05:50PM
04:45PM
04:10PM
Oct-23-24 10:01AM
09:00AM
Oct-07-24 04:10PM
Sep-24-24 09:30AM
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It operates through the Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded in 2018, and is headquartered in Brea, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Keel Paul AChief Executive OfficerAug 13 '24Buy16.8730,000506,100402,605Aug 14 04:40 PM
Hammes Eric D.Chief Financial OfficerAug 12 '24Buy16.3324,532400,60824,532Aug 13 06:01 PM